Drug Profile
Research programme: HIV prophylaxis vaccine - Ayala Pharmaceuticals
Alternative Names: Lovaxin HLatest Information Update: 23 Jan 2023
Price :
$50
*
At a glance
- Originator Advaxis
- Developer Ayala Pharmaceuticals
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections